In this case, ARID1A heterozygosity may suffice for oncogenesis during points of low ARID1A expression, which may account for the ARID1A genetic differences observed between the present mouse model and epithelial ovarian cancer models29,30. The gene discussed is ARID1A; the disease is ovarian carcinoma.